Skip to main content
. Author manuscript; available in PMC: 2020 Jan 9.
Published in final edited form as: Circ Genom Precis Med. 2019 Nov 22;12(12):e002711. doi: 10.1161/CIRCGEN.119.002711

Table 1. Baseline Characteristics of UK Biobank Participants Included in This Study and Numbers of Outcome Events.

Characteristic Mean (SD) or N (%)
Sample size 367 703 (100)
Male 168 799 (45.9)
Age at baseline 57.2 (8.1)
Body mass index 27.3 (4.8)
Systolic blood pressure 137.6 (18.6)
Diastolic blood pressure 82.0 (10.1)
Smoking status (current/ex/never)* 37 866 (10.3)/185 704
(50.5)/143 777 (39.1)
Alcohol status (current/ex/never)* 342 797 (93.2)/12 732
(3.5)/11 646 (3.2)
History of type 2 diabetes mellitus 15 834 (4.3)
Coronary artery disease 29 278 (8.0)
Ischemic cerebrovascular event (all) 8084 (2.2)
    Ischemic stroke 4602 (1.3)
    Transient ischemic attack 3962 (1.1)
Hemorrhagic stroke (all) 1981 (0.5)
    Intracerebral hemorrhage 1064 (0.3)
    Subarachnoid hemorrhage 1084 (0.3)
Aortic aneurysm (all) 1849 (0.5)
    Abdominal aortic aneurysm 1094 (0.3)
    Thoracic aortic aneurysm 347 (0.1)
Venous thromboembolism (all) 14 097 (3.8)
    Deep vein thrombosis 9454 (2.6)
    Pulmonary embolism 6148 (1.7)
Hypertension 125 846 (34.2)
Peripheral vascular disease 3415 (0.9)
Aortic valve stenosis 2244 (0.6)
Atrial fibrillation 16 945 (4.6)
Heart failure 6712 (1.8)
Chronic kidney disease 6321 (1.7)
*

Excluding 356 participants with smoking status absent and 528 participants with alcohol consumption status absent.